SLC22A12 and gout: Allopurinol, a xanthine oxidoreductase (XOR) inhibitor developed in the 1960s, and benzbromarone (BZB), a urate transporter 1 (URAT-1) inhibitor developed in the 1970s, are long-term drugs widely utilized for hyperuricemia/gout.